"Participants In Dementia Prevention Research Motivated By Altruism"
Researchers report that people who participate in dementia prevention trials are primarily motivated by altruism. The findings are published in Alzheimer’s & Dementia. “For the most part, people appeared satisfied with their experience in a clinical trial,” said author, Mary Sano, PhD, associate dean of clinical research and director of the Alzheimer’s Disease Research Center at the Icahn School of Medicine at Mount Sinai. “A big takeaway is how altruism and giving back are important to participants. We were also intrigued by the desire for increased social interactions.” Researchers found that trial participants preferred staff-administered assessments more than automated technologies; greater opportunity to challenge and improve their own mental function; and increased interaction with both study staff and other, older adults.
- Mary Sano, PhD, Associate Dean, Clinical Research, Professor, Psychiatry, Director, Alzheimer’s Disease Research Center, Icahn School of Medicine at Mount Sinai